Showing results (71-80 of 212) with videos related to

Sort By:
Pageof 22
British Journal of Haematology|December 19, 2025
Assessment of measurable residual disease in ovarian tissue collected for fertility preservation in patients in remission from acute myeloid leukaemia: A pilot studyAugustin Boudry, Florian Chevillon, Alice Marceau-Renaut, et al.
Pediatric Hematology and Oncology|January 6, 2018
Acute megakaryoblastic leukemia (excluding Down syndrome) remains an acute myeloid subgroup with inferior outcome in the French ELAM02 trialAnne-Charlotte Teyssier, Hélène Lapillonne, Marlene Pasquet, et al.
Blood|July 28, 2005
Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotypeNicolas Boissel, Aline Renneville, Valeria Biggio, et al.
Blood|October 5, 2010
C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutationsJohn A Pulikkan, Philomina S Peramangalam, Viola Dengler, et al.
Genes, Chromosomes & Cancer|May 13, 2021
Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemiasValentin Lestringant, Nicolas Duployez, Dominique Penther, et al.
American Journal of Hematology|March 12, 2014
Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1-RUNX1T1 fusion quantification on genomic DNANicolas Duployez, Olivier Nibourel, Alice Marceau-Renaut, et al.
Blood Advances|October 27, 2020
Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signatureAli Nehme, Hassan Dakik, Frédéric Picou, et al.
American Journal of Hematology|December 31, 2013
Fractionated gemtuzumab ozogamicin and standard dose cytarabine produced prolonged second remissions in patients over the age of 55 years with acute myeloid leukemia in late first relapseSylvain Pilorge, Sophie Rigaudeau, Florence Rabian, et al.
Blood|March 18, 2009
The favorable impact of CEBPA mutations in patients with acute myeloid leukemia is only observed in the absence of associated cytogenetic abnormalities and FLT3 internal duplicationAline Renneville, Nicolas Boissel, Nathalie Gachard, et al.
Experimental Hematology|November 9, 2010
Telomere deregulations possess cytogenetic, phenotype, and prognostic specificities in acute leukemiasValérie Capraro, Linda Zane, Delphine Poncet, et al.
Pageof 22